Standex director proposes $12.5K share sale
Each of Thomas Chorman's three prior sales covered 50 common shares; their stated aggregate market values were $15,278.00, $14,244.50 and $13,569.50.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
STANDEX INTERNATIONAL CORP (SXI) director Thomas E. Chorman gave notice of a proposed sale of 50 common shares, with an aggregate market value of $12,500.00. Fidelity Brokerage Services LLC is identified as broker, and the approximate sale date is November 2, 2026. The notice also lists prior sales by Thomas Chorman on August 3, September 1 and October 1, 2026.
Key Figures
Key Terms
Rule 144 regulatory
Restricted Stock Vesting financial
attorney-in-fact regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What were Thomas Chorman's recent prior SXI sale values?
AI-generated analysis. How Rhea-AI works. Not financial advice.